Thursday, Sept 11, 2003     Arrival and accommodation of participants. Friday, 12. September 2003   08:30-09:00 Registration at the Vanemuise Conference Hall 09:00-09:10 OPENING OF THE FORUM Prof. Toivo Maimets, Minister, Ministry of Education and Research, Estonia PricewaterhouseCoopers, , "Award of Biotechnology" EGeen, Estonian Genome Foundation, "Art Contest: DNA Double Helix" 09:10-10:50 OPENING SESSION Dr. Duncan McHale, Director and European Head of Clinical Pharmacogenomics, Sandwich Laboratories, Pfizer Ltd, UK "Using genetics to improve drug discovery and development" Dr. Ruth Taylor, Sr. Marketing Manager, IBM Life Sciences Information Based Medicine, USA "Information Based Medicine – Utilizing Health Care to Achieve Personalized Health Care" Leslie A. Platt, J.D., Principal&Leader, Health Sciences Research Compliance Group, Ernst&Young LLP, USA "Rewarding Medical Researchers For Doing What Is Right: An Emerging Consensus on Factors for Global Success" 10:50-11:10 Coffee/tea break 11:10-13:25 SESSION I Prof. Alan Wright, Cell and Molecular Genetics Section, MRC Human Genetics Unit, Western General Hospital, Edinburgh, UK "Genes, environment and complex disease" Dr. Krista Kruuv, Estonian Genome Project Foundation - Experience of the Year, Estonia "Estonian Genome Project" Dr. John Newton, Chief Executive Officer, UK Biobank Project, United Kingdom "The UK Biobank project" Dr. Struan Grant, DeCode Genetics, Reykjavik, Iceland "Genealogic Approach To Human Disease" Dr. Martin Yuille, Chief Scientist, MRC geneservice, United Kingdom "The Medical Research Council DNA Bank" 13:25-14:40 Lunch 14:40-15:50 SESSION II + parallel session Bioworkshop Dr. Andrew Bergen, Core Genotyping Facility, National Cancer Institute, USA "Genomic technology development activities at the Core Genotyping Facility of the National Cancer Institute" Prof. Paolo Gasparini, Associate Professor in Medical Genetics, Faculty of Medicine, Second University of Naples, Italy "Genetics of Hearing Loss" 15:50-16:10 Coffee/tea break 16:10-18:05 SESSION III + parallel session Bioworkshop Prof. Magnus Ingelman-Sundberg, Karolinska Institute, Stockholm, Sweden "Pharmacogenetics and drug therapy - the state of the art" Dr. Anne Cambon-Thomsen, Research Director, CNRS, Epidemiology and Analysis in Public Health Faculty of Medicine, INSERM, France "Assessing the use of biobanks: Open use of biobanks and ethical pitfalls; what or who do we protect?" Prof. Thomas Baldwin, Department of Philosophy, University of York, UK Stem Cell Steering Committee, Nuffield Council of Bioethics, UK "Applying ethical principles to the regulation of embryonic stem cell research" 20:00-22:00 Buffet Dinner in Sõbra Keskus (Võru 55F, Tartu) Saturday, 13. September 2003   09:00-10:30 SESSION IV Keynote Prof. Rolf M. Zinkernagel, Nobel Prize (1996), Institute of Experimental Immunology, University of Zurich, Switzerland "Immunological memory and vaccines" Prof. Adriano Aguzzi, Institute for Neuropathology, University of Zurich, Switzerland "Peripheral prion pathogenesis: a journey through gut, spleen and nerves" 10:30-10:50 Coffee/tea break 10:50-12:45 SESSION V Prof. Rudi Westendorp, Leiden University Medical Centre, Leiden, The Netherlands "The genetic control of longevity" Dr. Sulev Kõks, Department of Physiology, University of Tartu, Estonia "The Genetic Networks of Negative Emotions" Prof. Pierre Hainaut, Chief of Unit, Molecular Carcinogenesis, IARC, France "TP53 mutations and human molecular carcinogenesis" 12:45-14:00 Lunch 14:00-15:10 SESSION VI Prof. Hannu Raunio, University of Kuopio, Finland "How will pharmacogenomics affect drug treatment?" Dr. Malle Jürima-Romet, Director, Drug Development Programs, MDS Pharma Services, Montreal, Canada "Applications of pharmacogenetics to drug development" 15:10-15:30 Coffee/tea break 15:30-16:50 SESSION VII Prof. Torben Orntoft, Molecular Diganostics laboratory, Department of Clinical Biocheministry, Åarhus University Hospital, Denmark "DNA microarrays for classification of patients" Dr. Markus Beier, Director Application, Intellectual Property Advisor, febit ag, Germany "Instant utilization of sequence databases for microarray based genome research" Prof. Bo Samuelsson, Chairman of ScanBalt, Vice-Chancellor of Göteborg University, Sweden "ScanBalt Bioregion in progress – a way to reach critical mass in the EU and globally"